Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCAHCardinal Health
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | CAH | GILD |
|---|
| Close | 232.54 | 147.68 |
| Market Cap | $54.1B | $183B |
| 1M | −1.32% | +6.31% |
| P/E (TTM) | 31.6 | — |
| Forward P/E | 18.9 | 25.3 |
| P/E 5-Yr Percentile | 30 | — |
| P/S | 0.2 | 6.0 |
| P/B | 54.2 | 15.3 |
| Dividend Yield | 1.88% | 3.98% |
| Latest Quarter Revenue | $64.5B | $7.8B |
| Revenue YoY | +7.1% | +10.2% |
| Gross Margin | 4.4% | 79.8% |
| Latest Quarter EPS | — | -8.45 |
| Avg Post-Earnings Move | ±1.4% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.09% | 3.01% |
| 90-Day Net Insider Buying | −$59.6M | −$15.4M |
CAH · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
